Peptide Synthesis Launch
July 1999

Dalton Chemical Laboratories, a longtime leader in commercial oligo supply in Canada, has expanded its biopolymer operation with the launch of a custom peptide synthesis operation. The same commitment of quality and service that has made Dalton Canada's Core Facility^TM is now available for a broad range of peptide related services. The peptides will be analyzed by MS to confirm identity and a combination of CE and HPLC to confirm purity.

The launch will occur during the 2nd week of July, and is designed to give Canadian researchers a commercial source within Canada to supply to their biopolymer needs. Founded in 1986, Dalton has a broad range of chemistry expertise that is well utilized in the synthesis of bioactive molecules.

For peptides, special synthesis or analytical projects, Dalton offers a range of capabilities and technologies to assist drug development and research.
Contact us for more information.

Back